Bio-Shield 2019-nCoV IgG (C1148/C1196)

Bio Shield

Principle: An indirect ELISA method

Automation: Yes

Approvals: Currently Under approval by FDA, Pending CE IVD mark

Suitability: For Medical Professionals and Scientists

Capital equipment required: Yes - A typical ELISA photometer

Description:

Bio-Shield 2019-nCoV IgG, is a semi-quantitative ELISA test for the determination of IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens


Key Points:
  • Semi-quantitative ELISA test with single-break strip plate with 48 wells (6 strips) or 96 wells (12 strips)
  • High Sensitivity (97.43% ) and Specificity (99.85%)
  • Test time: 90 min
  • Compatible with automated ELISA systems
  • Shelf Life: 12 months | Storage 2-8 °C
Company contact details:

ProGnosis Biotech S.A view full details
Greece

Website: Visit Website
Tel: + 30-2410623922